Cipta Sarana Medika Tbk. vs Semen Indonesia (Persero) Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Semen Indonesia (Persero) Tbk. trades at Rp1,450 (market cap 9.72T, 11.28M 24h volume). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 61.5× Cipta Sarana Medika Tbk.'s market cap, and Semen Indonesia (Persero) Tbk. is more actively traded (11.28M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | SMGR | |
|---|---|---|
Market Cap | 158.12B | 9.72T |
Volume | 8.21M | 11.28M |
Lot | 82.15K | 112.8K |
Turnover | 515.2M | 16.37B |
Average Price | 62.72 | 1,451.01 |
Value | 515.2M | 16.37B |
Indicative Equilibrium Price | 63 | 1,450 |
Indicative Equilibrium Volume | 1.33K | 2.71K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →